Matti Annala
Matti Annala
Researcher, Tampere University
Verified email at tuni.fi
Title
Cited by
Cited by
Year
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
Cell 155 (2), 462-477, 2013
34762013
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
24502013
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
16222015
The evolutionary history of lethal metastatic prostate cancer
G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ...
Nature 520 (7547), 353-357, 2015
10512015
Evaluation of methods for modeling transcription factor sequence specificity
MT Weirauch, A Cote, R Norel, M Annala, Y Zhao, TR Riley, ...
Nature biotechnology 31 (2), 126-134, 2013
3222013
Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer
AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ...
JAMA oncology 2 (12), 1598-1606, 2016
2602016
Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer
M Annala, G Vandekerkhove, D Khalaf, S Taavitsainen, K Beja, ...
Cancer discovery 8 (4), 444-457, 2018
2462018
Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer
AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ...
JNCI: Journal of the National Cancer Institute 109 (12), 2017
2252017
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ...
The Journal of clinical investigation 123 (2), 2013
2092013
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
Q Huang, T Whitington, P Gao, JF Lindberg, Y Yang, J Sun, MR Väisänen, ...
Nature genetics 46 (2), 126-135, 2014
1632014
Analysis of circulating cell-free DNA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors
D Quigley, JJ Alumkal, AW Wyatt, V Kothari, A Foye, P Lloyd, R Aggarwal, ...
Cancer discovery 7 (9), 999-1005, 2017
1602017
Treatment outcomes and tumor loss of heterozygosity in germline DNA repair–deficient prostate cancer
M Annala, WJ Struss, EW Warner, K Beja, G Vandekerkhove, A Wong, ...
European urology 72 (1), 34-42, 2017
1432017
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2 …
DJ Khalaf, M Annala, S Taavitsainen, DL Finch, C Oja, J Vergidis, ...
The Lancet Oncology 20 (12), 1730-1739, 2019
1422019
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network
KM Holmes, M Annala, CYX Chua, SM Dunlap, Y Liu, N Hugen, ...
Proceedings of the National Academy of Sciences 109 (9), 3475-3480, 2012
1012012
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
BC Parker, M Engels, M Annala, W Zhang
The Journal of pathology 232 (1), 4-15, 2014
902014
Circulating tumor DNA reveals clinically actionable somatic genome of metastatic bladder cancer
G Vandekerkhove, T Todenhöfer, M Annala, WJ Struss, A Wong, K Beja, ...
Clinical cancer research 23 (21), 6487-6497, 2017
862017
Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer
G Vandekerkhove, WJ Struss, M Annala, HML Kallio, D Khalaf, ...
European urology 75 (4), 667-675, 2019
852019
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
L Latonen, E Afyounian, A Jylhä, J Nättinen, U Aapola, M Annala, ...
Nature communications 9 (1), 1-13, 2018
852018
Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long noncoding RNA in prostate cancer
A Ylipää, K Kivinummi, A Kohvakka, M Annala, L Latonen, M Scaravilli, ...
Cancer research 75 (19), 4026-4031, 2015
682015
Fusion genes and their discovery using high throughput sequencing
MJ Annala, BC Parker, W Zhang, M Nykter
Cancer letters 340 (2), 192-200, 2013
562013
The system can't perform the operation now. Try again later.
Articles 1–20